Clinical Trial Update: Steady-state Pharmacokinetics of BIA 2-093 and Oxcarbazepine in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the steady-state pharmacokinetics of the candidate BIA 2-093 and oxcarbazepine in healthy volunteers to inform dosing and potential int…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• BIA 2-093
• Oxcarbazepine (Oxcarbazepine)

Snippet

Sponsor: Bial - Portela C S.A. | Conditions: Epilepsy | Phase 1 | Status: COMPLETED | Results posted: 2015-01-01